Nath Bio-Genes (India) Limited (NSE: NATHBIOGEN)

Market Cap	3.55B
Revenue (ttm)	3.51B
Net Income (ttm)	393.73M
Shares Out	19.00M
EPS (ttm)	20.64
PE Ratio	9.05
Forward PE	n/a
Dividend	2.00 (1.08%)
Ex-Dividend Date	Aug 9, 2024

Volume	12,366
Open	190.00
Previous Close	188.51
Day's Range	182.03 - 192.10
52-Week Range	167.15 - 264.31
Beta	1.33
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 22, 2025

About Nath Bio-Genes (India)

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities. The company offers fiber and oil seeds, including cotton and mustard; seeds for field crops, such as bajra, corn, paddy, wheat, and jowar; fruit seeds; and seeds for vegetables comprising chilli, onion, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, sweet pepper, green peas, pumpkin,...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1979
• Employees: 423
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: NATHBIOGEN

Financial Performance

In 2023, Nath Bio-Genes (India)'s revenue was 3.33 billion, an increase of 10.42% compared to the previous year's 3.01 billion. Earnings were 396.19 million, an increase of 13.16%.